Prolonged B-cell depletion in MuSK myasthenia gravis following rituximab treatment.
Type
Journal articleSubject
Antibodies, Monoclonal, Murine-DerivedAntigens, CD19
B-Lymphocytes
Cell Count
Fatty Acids, Monounsaturated
Female
Humans
Immunologic Deficiency Syndromes
Immunologic Factors
Middle Aged
Myasthenia Gravis
Rituximab
Permalink
https://hdl.handle.net/10161/10207Published Version (Please cite this version)
10.1002/mus.24063Publication Info
(2013). Prolonged B-cell depletion in MuSK myasthenia gravis following rituximab treatment.
Muscle Nerve, 48(6). pp. 992-993. 10.1002/mus.24063. Retrieved from https://hdl.handle.net/10161/10207.This is constructed from limited available data and may be imprecise. To cite this
article, please review & use the official citation provided by the journal.
Collections
More Info
Show full item recordScholars@Duke
Jeffrey Guptill
Adjunct Associate Professor in the Department of Neurology
Donald Benjamin Sanders
Professor of Neurology
Research Interests: 1. Therapy of neuromuscular disease - immunologic and neuromuscular
facilitating agents for myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome
(LEMS). 2. Clinical trials in nerve, muscle and neuromuscular diseases
Alphabetical list of authors with Scholars@Duke profiles.
Articles written by Duke faculty are made available through the campus open access policy. For more information see: Duke Open Access Policy
Rights for Collection: Scholarly Articles
Works are deposited here by their authors, and represent their research and opinions, not that of Duke University. Some materials and descriptions may include offensive content. More info